You are here
Prescription medicine determinations and designations
Find out more about Prescription medicines determination and designation notices
Filter results
You can narrow down the results using the filters
Search
280 result(s) found, displaying 1 to 25
- Designation or determinationNotice for irinotecan (as sucrosofate) (Servier Laboratories (Aust) Pty Ltd)Orphan drug
- Designation or determinationNotice for irinotecan (as sucrosofate) (Servier Laboratories (Aust) Pty Ltd)Priority review
- Designation or determinationNotice for iptacopan (Novartis Pharmaceuticals Australia Pty Ltd)Orphan drug
- Designation or determinationNotice for penpulimab (Specialised Therapeutics Pharma Pty Ltd)Orphan drug
- Designation or determinationNotice for elranatamab (Pfizer Australia Pty Ltd)Provisional determination
- Designation or determinationNotice for valoctocogene roxaparvovec (BioMarin Pharmaceuticals Australia Pty Ltd)Orphan drug
- Designation or determinationNotice for mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein (Moderna Australia Pty Ltd)Priority review
- Designation or determinationNotice for pembrolizumab (Merck Sharp & Dohme (Australia) Pty Ltd)Orphan drug
- Designation or determinationNotice for tepotinib (as hydrochloride monohydrate) (Merck Healthcare Pty Ltd)Orphan drug
- Designation or determinationNotice for tozinameran and famtozinameran (Pfizer Australia Pty Ltd)Provisional determination
- Designation or determinationNotice for lanadelumab (Takeda Pharmaceuticals Australia Pty Ltd)Orphan drug
- Designation or determinationNotice for dostarlimab (GlaxoSmithKline Australia Pty Ltd)Priority review
- Designation or determinationNotice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd)Priority review
- Designation or determinationNotice for sirolimus/rapamycin (AFT Pharmaceuticals Pty Ltd)Orphan drug
- Designation or determinationNotice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd)Orphan drug
- Designation or determinationNotice for etranacogene dezaparvovec (CSL Behring Australia Pty Ltd)Provisional determination
- Designation or determinationNotice for sacituzumab govitecan (Gilead Sciences Pty Ltd)Priority review
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »